BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15001467)

  • 21. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation.
    Badour K; Zhang J; Shi F; Leng Y; Collins M; Siminovitch KA
    J Exp Med; 2004 Jan; 199(1):99-112. PubMed ID: 14707117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
    Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.
    Jin Y; Mazza C; Christie JR; Giliani S; Fiorini M; Mella P; Gandellini F; Stewart DM; Zhu Q; Nelson DL; Notarangelo LD; Ochs HD
    Blood; 2004 Dec; 104(13):4010-9. PubMed ID: 15284122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Wiskott-Aldrich syndrome: disordered actin dynamics in haematopoietic cells.
    Thrasher AJ; Burns S; Lorenzi R; Jones GE
    Immunol Rev; 2000 Dec; 178():118-28. PubMed ID: 11213796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton.
    Imai K; Nonoyama S; Miki H; Morio T; Fukami K; Zhu Q; Aruffo A; Ochs HD; Yata J; Takenawa T
    Clin Immunol; 1999 Aug; 92(2):128-37. PubMed ID: 10444357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease mechanism: unravelling Wiskott-Aldrich syndrome.
    Kirchhausen T; Rosen FS
    Curr Biol; 1996 Jun; 6(6):676-8. PubMed ID: 8793292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity.
    Ham H; Guerrier S; Kim J; Schoon RA; Anderson EL; Hamann MJ; Lou Z; Billadeau DD
    J Immunol; 2013 Apr; 190(7):3661-9. PubMed ID: 23455509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.
    Notarangelo LD; Ochs HD
    Curr Opin Immunol; 2003 Oct; 15(5):585-91. PubMed ID: 14499269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody.
    Jochems C; Hodge JW; Fantini M; Tsang KY; Vandeveer AJ; Gulley JL; Schlom J
    Int J Cancer; 2017 Aug; 141(3):583-593. PubMed ID: 28477372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activation.
    Serrano-Pertierra E; Cernuda-Morollón E; López-Larrea C
    Eur J Immunol; 2012 Aug; 42(8):2142-51. PubMed ID: 22585739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
    Thrasher AJ
    Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WASH has a critical role in NK cell cytotoxicity through Lck-mediated phosphorylation.
    Huang L; Zhu P; Xia P; Fan Z
    Cell Death Dis; 2016 Jul; 7(7):e2301. PubMed ID: 27441653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fc gamma RIIIA-mediated signaling involves src-family lck in human natural killer cells.
    Pignata C; Prasad KV; Robertson MJ; Levine H; Rudd CE; Ritz J
    J Immunol; 1993 Dec; 151(12):6794-800. PubMed ID: 8258691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype.
    Linder S; Wintergerst U; Bender-Götze C; Schwarz K; Pannicke U; Aepfelbacher M
    Immunol Cell Biol; 2003 Apr; 81(2):130-6. PubMed ID: 12631236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel neural Wiskott-Aldrich syndrome protein (N-WASP) binding protein, WISH, induces Arp2/3 complex activation independent of Cdc42.
    Fukuoka M; Suetsugu S; Miki H; Fukami K; Endo T; Takenawa T
    J Cell Biol; 2001 Feb; 152(3):471-82. PubMed ID: 11157975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.
    Mizesko MC; Banerjee PP; Monaco-Shawver L; Mace EM; Bernal WE; Sawalle-Belohradsky J; Belohradsky BH; Heinz V; Freeman AF; Sullivan KE; Holland SM; Torgerson TR; Al-Herz W; Chou J; Hanson IC; Albert MH; Geha RS; Renner ED; Orange JS
    J Allergy Clin Immunol; 2013 Mar; 131(3):840-8. PubMed ID: 23380217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular biology of the Wiskott-Aldrich syndrome.
    Rengan R; Ochs HD
    Rev Immunogenet; 2000; 2(2):243-55. PubMed ID: 11258421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and function of the Wiskott-Aldrich syndrome protein.
    Ochs HD; Notarangelo LD
    Curr Opin Hematol; 2005 Jul; 12(4):284-91. PubMed ID: 15928485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.